August 1, 2023 BY DOCUSIGN Daniel L. Flynn, Ph.D. Re: Transition Agreement Dear Dan:Transition Agreement • October 30th, 2023 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • Kansas
This letter is the agreement between you and the Company concerning your transition to your voluntary retirement (the “Transition Agreement”). Attached as Exhibit A is the form of the Consulting Agreement between you and the Company (the “Consulting Agreement” and, together with the “Transition Agreement”). Your rights and obligations under each of the Agreements are contingent on your execution of both Agreements.
CONSULTING AGREEMENTConsulting Agreement • October 30th, 2023 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • Kansas
THIS CONSULTING AGREEMENT (together with the attached Business Terms Exhibit, the “Agreement”), is made as of January 1, 2024 (the “Effective Date”) by and between Deciphera Pharmaceuticals, LLC, a Delaware limited liability company with a principal business address at 200 Smith Street, Waltham, MA 02451 (“Deciphera”), and Daniel L. Flynn (“Consultant”). Deciphera desires to have the benefit of Consultant’s knowledge and experience, and Consultant desires to provide services to Deciphera, all as provided in this Agreement. Deciphera and Consultant are referred to herein collectively as the “Parties” and individually as a “Party”.
